Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TDS Pharm CoXKRX:464280 40 OCF Margin % is 19.14% as of Jun. 2026, which is 47% above its 10-year median of 12.98. GuruFocus rates XKRX:464280 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review. Among 965 Drug Manufacturers companies, TDS Pharm Co ranks better than 77.51% on this metric.
The historical rank and industry rank for TDS Pharm Co's OCF Margin % or its related term are showing as below:
XKRX:464280'
s OCF Margin % Range Over the Past 10 Years
Min: 10.96 Med: 12.98 Max: 18.57
Current: 19.83
During the past 6 years, the highest OCF Margin % of TDS Pharm Co was 18.57%. The lowest was 10.96%. And the median was 12.98%.
XKRX:464280's OCF Margin % is ranked better than 77.51% of 965
companies
in the Drug Manufacturers industry
Industry Median: 10.04
vs XKRX:464280: 19.83
The historical data trend for TDS Pharm Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:464280 vs LLY, JNJ, ABBV: OCF Margin % Comparison
For the Drug Manufacturers - General subindustry, TDS Pharm Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TDS Pharm Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where TDS Pharm Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDS Pharm Co (XKRX:464280) has a OCF Margin % of 19.14% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TDS Pharm Co and its competitors. This is 47% above median its historical median of 12.98. Over the past decade, TDS Pharm Co's OCF Margin % has ranged from 10.96 to 18.57. According to the industry distribution chart, TDS Pharm Co ranks #217 out of 965 companies in the Drug Manufacturers industry, placing it in the top 22.5%.
Is TDS Pharm Co's OCF Margin % too high?
TDS Pharm Co's current OCF Margin % of 19.14% is 47% above median its 10-year median of 12.98. Over the past 10 years, this metric has ranged from a low of 10.96 to a high of 18.57. The Drug Manufacturers industry median OCF Margin % is 10.04. TDS Pharm Co's value of 19.14% is 90.6% above this industry median. Based on the distribution chart, TDS Pharm Co ranks #217 out of 965 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TDS Pharm Co ranks #217 out of 965 companies for OCF Margin %. This places TDS Pharm Co in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 10.04. TDS Pharm Co's value of 19.14% is 90.6% above this benchmark. Historically, TDS Pharm Co's own OCF Margin % has ranged from 10.96 to 18.57 over the past decade. While the company's 10-year median is 12.98 vs. the industry median of 10.04, TDS Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 965 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TDS Pharm Co's current OCF Margin % of 19.14% is 90.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TDS Pharm Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TDS Pharm Co's current OCF Margin % is 19.14%, which is 47% above median its own 10-year median of 12.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current OCF Margin % of 19.14%. The current OCF Margin % is 19.14%, which is 47% above median its 10-year median of 12.98 and 90.6% above the Drug Manufacturers industry median of 10.04. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current OCF Margin % is 19.14% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score
Get the complete analysis for XKRX:464280
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:464280 has been successfully added to your 
